CūtisCare Increasing Awareness This National Diabetes Month To Save Limbs and Lives

CūtisCare, a leading provider of wound care management services to hospitals and physicians, is continuing our fight this month to raise awareness regarding diabetes and the available treatment options to help save limbs and lives.

According to the CDC, diabetes currently adversely impacts the lives of approximately 34 million Americans, and that number is continuing to increase each year. About 25% of people with diabetes will develop foot ulcers, and 1% end up with an amputation in their lifetime. However, as many as 85% of potential amputations can be avoided when advanced modalities, such as hyperbaric oxygen therapy, or HBOT, are added to a treatment plan.

There is good news on the horizon though. Many of these amputations are preventable. HBOT is one therapy that is showing great promise. Louis Pilati MD, CutisCare’s Medical Advisory Board Member, expounds on the manifold benefits of HBOT for patients with Wagner Grade 3 or higher:

The physiologic effect of hyperbaric oxygen treatment of the diabetic foot patient is to reverse the impediments caused by hypoxemia or below-normal level of oxygen in your blood. Hyperbaric oxygen increases the dissolved oxygen and the amount of oxygenated plasma dissolved in tissue. It also increases reactive oxygen and nitrogen species to increase growth factor synthesis, stem cell proliferation, diminished inflammatory response, and enhanced white blood cell killing of bacteria.

Thousands of hospitals and healthcare practices are still not equipped to provide limb-saving treatments, so many patients with diabetes are not aware that these treatment options exist. As a partner to the nation’s leading healthcare facilities, the team at CūtisCare is dedicated to bringing awareness to early prevention methods those with diabetes can take to prevent amputations that can result from foot ulcers and other large wounds. Visit cutiscareusa.com, as well as our social media channels, throughout November to access educational resources highlighting this life-saving treatment option, a foot care guide for how to reduce complications, take a Diabetes Risk Test, or even to find a treatment provider near you.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version